{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T18:06:06Z","timestamp":1794679566055,"version":"4.9.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review provides an update on the new interleukin-1 (IL-1) cytokine family members in inflammatory diseases with focus on recent findings concerning the family members IL-36, IL-37, and IL-38 and their different expression patterns.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>The IL-1 cytokines are known to be involved in many different inflammatory and autoimmune diseases. The latest IL-1 family members, IL-36, IL-37, and IL-38 have been shown to be differently regulated during course of disease. Studies of patients suffering from inflammatory diseases revealed that those cytokines are upregulated in the serum as well as in inflamed tissue. Both, epithelial cells and infiltrating peripheral mononuclear blood cells serve as source of the cytokines IL-36, IL-37, and IL-38 triggering different outcomes. These results could be confirmed in different mouse models and in-vitro and ex-vivo studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>IL-36, IL-37, and IL-38 are involved in the pathogenesis of the inflammatory diseases psoriasis, rheumatoid arthritis, gout, systemic lupus erythematosus as well as Crohn's disease. Thereby IL-36 acts proinflammatory triggering further inflammatory mediators. In contrast, IL-37 and IL-38 are upregulated to counteract. Understanding the imbalance of the IL-1 family is crucial for future therapeutics.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000361","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T17:09:20Z","timestamp":1481044160000},"page":"208-213","source":"Crossref","is-referenced-by-count":46,"title":["The novel interleukin-1 cytokine family members in inflammatory diseases"],"prefix":"10.1097","volume":"29","author":[{"given":"Madelaine","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel J.","family":"Hueber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230828","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1471-4906(01)02040-3","article-title":"A new nomenclature for IL-1-family genes","volume":"22","author":"Sims","year":"2001","journal-title":"Trends Immunol"},{"key":"R2-20230828","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ni1110-973","article-title":"IL-1 family nomenclature","volume":"11","author":"Dinarello","year":"2010","journal-title":"Nat Immunol"},{"key":"R3-20230828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-065X.2008.00701.x","article-title":"The interleukin-1 receptor\/Toll-like receptor superfamily: 10 years of progress","volume":"226","author":"O\u2019Neill","year":"2008","journal-title":"Immunol Rev"},{"key":"R4-20230828","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"R5-20230828","doi-asserted-by":"crossref","first-page":"13677","DOI":"10.1074\/jbc.M400117200","article-title":"Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs","volume":"279","author":"Towne","year":"2004","journal-title":"J Biol Chem"},{"key":"R6-20230828","doi-asserted-by":"crossref","first-page":"13723","DOI":"10.1073\/pnas.212519099","article-title":"A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity","volume":"99","author":"Bufler","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-20230828","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood-2012-06-439026","article-title":"IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells","volume":"120","author":"Vigne","year":"2012","journal-title":"Blood"},{"key":"R8-20230828","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1189\/jlb.3RI1014-495R","article-title":"Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions","volume":"97","author":"Gabay","year":"2015","journal-title":"J Leukoc Biol"},{"key":"R9-20230828","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1073\/pnas.1121534109","article-title":"IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist","volume":"109","author":"van de Veerdonk","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-20230828","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1084\/jem.20070157","article-title":"Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation","volume":"204","author":"Blumberg","year":"2007","journal-title":"J Exp Med"},{"key":"R11-20230828","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jid.2016.04.038","article-title":"IL36RN mutations impact on protein expression and function: a basis for genotype-phenotype correlation in pustular diseases","volume":"136","author":"Tauber","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R12-20230828","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5021\/ad.2016.28.4.451","article-title":"Immunohistochemical comparison of IL-36 and the IL-23\/Th17 axis of generalized pustular psoriasis and acute generalized exanthematous pustulosis","volume":"28","author":"Song","year":"2016","journal-title":"Ann Dermatol"},{"key":"R13-20230828","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tcb.2004.02.002","article-title":"Adaptable adaptors for coated vesicles","volume":"14","author":"Robinson","year":"2004","journal-title":"Trends Cell Biol"},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.jid.2016.06.618","article-title":"AP1S3 mutations cause skin autoinflammation by disrupting keratinocyte autophagy and up-regulating IL-36 production","volume":"136","author":"Mahil","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R15-20230828","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"R16-20230828","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2007.08.009","article-title":"Immune regulation in psoriasis and psoriatic arthritis \u2013 recent developments","volume":"114","author":"Hueber","year":"2007","journal-title":"Immunol Lett"},{"key":"R17-20230828","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"R18-20230828","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/annrheumdis-2012-202264","article-title":"The novel cytokine interleukin-36alpha is expressed in psoriatic and rheumatoid arthritis synovium","volume":"72","author":"Frey","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R19-20230828","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36alpha, beta and gamma, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease","volume":"184","author":"Boutet","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"R20-20230828","doi-asserted-by":"crossref","first-page":"e101954","DOI":"10.1371\/journal.pone.0101954","article-title":"Blockade of IL-36 receptor signaling does not prevent from TNF-induced arthritis","volume":"9","author":"Derer","year":"2014","journal-title":"PLoS One"},{"key":"R21-20230828","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/ar4192","article-title":"The severity of experimental arthritis is independent of IL-36 receptor signaling","volume":"15","author":"Lamacchia","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R22-20230828","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","article-title":"Inflammatory bowel disease","volume":"28","author":"Kaser","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"R23-20230828","article-title":"IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo","author":"Scheibe","year":"2016","journal-title":"Gut"},{"key":"R24-20230828","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MIB.0000000000000654","article-title":"Increased expression of interleukin-36, a member of the interleukin-1 cytokine family, in inflammatory bowel disease","volume":"22","author":"Nishida","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J Clin Pathol"},{"key":"R26-20230828","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/labinvest.2009.148","article-title":"Local overexpression of interleukin-1 family, member 6 relates to the development of tubulointerstitial lesions","volume":"90","author":"Ichii","year":"2010","journal-title":"Lab Invest"},{"key":"R27-20230828","doi-asserted-by":"crossref","first-page":"19588","DOI":"10.3390\/molecules201019588","article-title":"Elevated expression and pro-inflammatory activity of IL-36 in patients with systemic lupus erythematosus","volume":"20","author":"Chu","year":"2015","journal-title":"Molecules"},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0625.2000.009001001.x","article-title":"Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop","volume":"9","author":"Terui","year":"2000","journal-title":"Exp Dermatol"},{"key":"R29-20230828","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL-36beta, and IL-36gamma) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J Biol Chem"},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.celrep.2015.12.072","article-title":"Neutrophil-derived proteases escalate inflammation through activation of IL-36 family cytokines","volume":"14","author":"Henry","year":"2016","journal-title":"Cell Rep"},{"key":"R31-20230828","doi-asserted-by":"crossref","first-page":"24880","DOI":"10.1038\/srep24880","article-title":"Neutrophil elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 receptor antagonist","volume":"6","author":"Macleod","year":"2016","journal-title":"Sci Rep"},{"key":"R32-20230828","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/cyto.2002.0873","article-title":"Interleukin-1F7B (IL-1H4\/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production","volume":"18","author":"Kumar","year":"2002","journal-title":"Cytokine"},{"key":"R33-20230828","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1074-7613(00)80013-8","article-title":"Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response","volume":"10","author":"Novick","year":"1999","journal-title":"Immunity"},{"key":"R34-20230828","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1172\/JCI29404","article-title":"Gout: new insights into an old disease","volume":"116","author":"Martinon","year":"2006","journal-title":"J Clin Invest"},{"issue":"(suppl 1)","key":"R35-20230828","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1908","article-title":"The inflammatory process of gout and its treatment","volume":"8","author":"Cronstein","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R36-20230828","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s10067-015-3109-5","article-title":"IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response","volume":"35","author":"Zeng","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R37-20230828","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/apm.12467","article-title":"Elevated serum levels of interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis","volume":"123","author":"Yang","year":"2015","journal-title":"APMIS"},{"key":"R38-20230828","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.4049\/jimmunol.1401810","article-title":"IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation","volume":"194","author":"Ye","year":"2015","journal-title":"J Immunol"},{"key":"R39-20230828","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew325","article-title":"Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation","author":"Cavalli","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R40-20230828","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.imlet.2016.04.004","article-title":"IL-37 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption in vivo","volume":"175","author":"Saeed","year":"2016","journal-title":"Immunol Lett"},{"key":"R41-20230828","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1177\/0961203316646462","article-title":"Elevated plasma interleukin-37 levels in systemic lupus erythematosus patients","volume":"25","author":"Wu","year":"2016","journal-title":"Lupus"},{"key":"R42-20230828","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/107999001753289505","article-title":"Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14","volume":"21","author":"Bensen","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"R43-20230828","doi-asserted-by":"crossref","first-page":"20597","DOI":"10.1074\/jbc.M010095200","article-title":"Cloning and characterization of IL-1HY2, a novel interleukin-1 family member","volume":"276","author":"Lin","year":"2001","journal-title":"J Biol Chem"},{"key":"R44-20230828","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/art.39328","article-title":"Brief report: Interleukin-38 exerts antiinflammatory functions and is associated with disease activity in systemic lupus erythematosus","volume":"67","author":"Rudloff","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R45-20230828","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjw006","article-title":"Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses","author":"Mora","year":"2016","journal-title":"J Mol Cell Biol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201703000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T05:15:01Z","timestamp":1693199701000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201703000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000361","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}